GORE® EXCLUDER® AAA ENDOPROSTHESIS
Report
- Report Number
- 2017233-2014-00545
- Event Type
- Injury
- Date Received
- October 22, 2014
- Date of Event
- September 15, 2014
- Report Date
- October 23, 2014
- Manufacturer
- W.L. GORE & ASSOCIATES
- Product Code
- MIH
- PMA / PMN Number
- P020004
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IL, US
- Reporter Occupation
- PHYSICIAN
Narratives
THE REVIEW OF THE MANUFACTURING PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS.(B)(4). THE CAUSE OF THE DISTAL TYPE I ENDOLEAK IS REPORTEDLY UNKNOWN.
PATIENT MEDICATIONS INCLUDE POTASSIUM CHLORIDE, JANUVIA, FLOMAX, TORSEMIDE, ASPIRIN, ATENOLOL, ATORVASTATIN, BISACODYL, DOCUSATE SODIUM, FERROUS SULFATE, GLIMEPIRIDE, LISINOPRIL, MAGNESIUM HYDROXIDE, PANTOPROAZOLE, AND POLYETHYLENE. ADDITIONAL DEVICE IMPLANTED AND INVOLVED IN THE EVENT: PLC181200/12609693.
ON (B)(6) 2014, THE PATIENT UNDERWENT TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM WITH FOUR GORE® EXCLUDER® AAA ENDOPROSTHESES. AROUND (B)(6) 2014, A FOLLOW-UP COMPUTED TOMOGRAPHY SCAN REPORTEDLY SHOWED EVIDENCE OF PROXIMAL AND DISTAL TYPE I ENDOLEAKS WITH NO EVIDENCE OF ANEURYSM ENLARGEMENT. THE EXACT CAUSES OF THE TYPE I ENDOLEAKS ARE REPORTEDLY UNKNOWN. HOWEVER, IT WAS REPORTED THERE WAS NON-CIRCUMFERENTIAL CALCIFICATION IN THE PROXIMAL NECK THAT MAY BE CONTRIBUTING TO THE PROXIMAL TYPE I ENDOLEAK, AND ONE SIDE OF THE TRUNK-IPSILATERAL LEG COMPONENT DID NOT APPEAR TO BE APPOSED TO THE PROXIMAL NECK. ON (B)(6) 2014, AN ADDITIONAL PROCEDURE WAS PERFORMED TO TREAT THE ENDOLEAKS. FOR THE DISTAL TYPE I ENDOLEAK, A CONTRALATERAL LEG COMPONENT WAS IMPLANTED FOR DISTAL EXTENSION. ANGIOGRAPHY SHOWED NO FURTHER EVIDENCE OF THE DISTAL LEAK. AN APTUS ENDOSYSTEM WAS USED IN AN ATTEMPT TO OBTAIN BETTER PROXIMAL WALL APPOSITION WITH ENDOSTAPLES. AFTER 20 ENDOSTAPLES WERE PLACED IN THE PROXIMAL NECK, ANGIOGRAPHY REPORTEDLY STILL SHOWED EVIDENCE OF THE PROXIMAL LEAK. AS IT WAS REPORTED THERE WAS NO ROOM FOR PROXIMAL EXTENSION DUE TO NEEDING TO PRESERVE AN ACCESSORY RENAL ARTERY IN THE PROXIMAL NECK, THE PROCEDURE WAS CONCLUDED WITH A POSSIBLE PLAN OF INTERVENING IN THE FUTURE. NO FURTHER ADVERSE EVENTS WERE REPORTED, AND THE PATIENT TOLERATED THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 673444 | GORE® EXCLUDER® AAA ENDOPROSTHESIS | SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT | MIH | W.L. GORE & ASSOCIATES | 10149235 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 89 YR | Hospitalization| R |